• NCI exited its majority stake in dietary supplements maker Laboratoires Herbolistique, selling to Yotta Capital Partners, Ouest Croissance, and other investors.
• NCI Dette Privée 1 provided mezzanine debt financing alongside the acquisition financing to support the company’s next growth phase.
• Herbolistique was founded in 2002 in La Verrie, France, producing plant-based natural supplements.
• NCI entered as majority shareholder in 2021; revenue rose to nearly EUR 15 million from EUR 10 million, headcount increased to 58.
• The deal marks the second investment by NCI’s private debt fund, following a transaction with Leader Group.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NCI SAS published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein.